✦ LIBER ✦

PAR10 COST-EFFECTIVENESS OF RITUXIMAB THERAPY FOR RHEUMATOID ARTHRITIS: A PAN-EUROPEAN ANALYSIS

✍ Scribed by A Kielhorn; A Rubbert; D Porter; S De Vita; B Brown; M Aristides; R Aultman; F Jost

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS11 COST-EFFECTIVENESS ANALYSIS OF RIT

✍ SF Lou; DY Chen; TT Cheng; CM Huang; HY Lin; CC Su; WC Tsai; JC Tseng; CC Wei; L 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

PAR4 COST-EFFECTIVENESS ANALYSIS OF RITU

✍ D Porter; G Lewis; B Brown; A Diamantopoulos; A Kielhorn 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PAR5 COST-EFFECTIVENESS OF RITUXIMAB AS

✍ A Rubbert; A Kielhorn; S Schach; B Brown 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PAR7 MODELLING OF THE COST-EFFECTIVENESS

✍ S De Vita; G Giuliani; A Diamantopoulos; B Brown; A Kielhorn 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PAR10 COST-EFFECTIVENESS AND COST-UTILIT

✍ M Eandi; O Zaniolo; S Iannazzo; L Pradelli 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Cost-effectiveness analysis of biologica

✍ Chiou, Chiun-Fang; Choi, Julie; Reyes, Carolina M 📂 Article 📅 2004 🏛 Expert Reviews 🌐 English ⚖ 102 KB